These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14767552)

  • 1. Increased expression of IGF II mRNA-binding protein 1 mRNA is associated with an advanced clinical stage and poor prognosis in patients with ovarian cancer.
    Gu L; Shigemasa K; Ohama K
    Int J Oncol; 2004 Mar; 24(3):671-8. PubMed ID: 14767552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human kallikrein gene 11 (KLK11) mRNA overexpression is associated with poor prognosis in patients with epithelial ovarian cancer.
    Shigemasa K; Gu L; Tanimoto H; O'Brien TJ; Ohama K
    Clin Cancer Res; 2004 Apr; 10(8):2766-70. PubMed ID: 15102682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skp2 overexpression is a prognostic factor in patients with ovarian adenocarcinoma.
    Shigemasa K; Gu L; O'Brien TJ; Ohama K
    Clin Cancer Res; 2003 May; 9(5):1756-63. PubMed ID: 12738731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer.
    Kusuda T; Shigemasa K; Arihiro K; Fujii T; Nagai N; Ohama K
    Oncol Rep; 2005 Jun; 13(6):1153-8. PubMed ID: 15870936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
    Shigemasa K; Tian X; Gu L; Tanimoto H; Underwood LJ; O'Brien TJ; Ohama K
    Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased MCL-1 expression is associated with poor prognosis in ovarian carcinomas.
    Shigemasa K; Katoh O; Shiroyama Y; Mihara S; Mukai K; Nagai N; Ohama K
    Jpn J Cancer Res; 2002 May; 93(5):542-50. PubMed ID: 12036450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Underexpression of cyclin-dependent kinase inhibitor p27 is associated with poor prognosis in serous ovarian carcinomas.
    Shigemasa K; Shiroyama Y; Sawasaki T; Fujii T; Nagai N; Parmley TH; O'Brien TJ; Ohama K
    Int J Oncol; 2001 May; 18(5):953-8. PubMed ID: 11295040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.
    Zhang J; Tang L; Chen Y; Duan Z; Xiao L; Li W; Liu X; Shen L
    Hum Pathol; 2015 Sep; 46(9):1331-40. PubMed ID: 26193797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival.
    Sun F; Ding W; He JH; Wang XJ; Ma ZB; Li YF
    BMC Cancer; 2015 Oct; 15():746. PubMed ID: 26487491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRSS3 expression is associated with tumor progression and poor prognosis in epithelial ovarian cancer.
    Ma R; Ye X; Cheng H; Ma Y; Cui H; Chang X
    Gynecol Oncol; 2015 Jun; 137(3):546-52. PubMed ID: 25735255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of CD44 expression in ovarian epithelial tumors].
    Qu P; Jiao S; Gao Q
    Zhonghua Zhong Liu Za Zhi; 2001 Jan; 23(1):46-9. PubMed ID: 11783069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of insulin-like growth factor-II messenger RNA-binding protein 1 is associated with tumor progression in patients with lung cancer.
    Kato T; Hayama S; Yamabuki T; Ishikawa N; Miyamoto M; Ito T; Tsuchiya E; Kondo S; Nakamura Y; Daigo Y
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):434-42. PubMed ID: 17255263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NEDD9 overexpression is associated with the progression of and an unfavorable prognosis in epithelial ovarian cancer.
    Wang H; Mu X; Zhou S; Zhang J; Dai J; Tang L; Xiao L; Duan Z; Jia L; Chen S
    Hum Pathol; 2014 Feb; 45(2):401-8. PubMed ID: 24439227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEA3 is the second Ets family transcription factor involved in tumor progression in ovarian carcinoma.
    Davidson B; Goldberg I; Gotlieb WH; Kopolovic J; Ben-Baruch G; Reich R
    Clin Cancer Res; 2003 Apr; 9(4):1412-9. PubMed ID: 12684413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivariate analysis by Cox proportional hazard model on prognosis of patient with epithelial ovarian cancer.
    Wang M; He Y; Shi L; Shi C
    Eur J Gynaecol Oncol; 2011; 32(2):171-7. PubMed ID: 21614907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma.
    White NM; Mathews M; Yousef GM; Prizada A; Popadiuk C; Doré JJ
    Br J Cancer; 2009 Oct; 101(7):1107-13. PubMed ID: 19707197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p27Kip1 expression is associated with clinical outcome in advanced epithelial ovarian cancer: multivariate analysis.
    Masciullo V; Ferrandina G; Pucci B; Fanfani F; Lovergine S; Palazzo J; Zannoni G; Mancuso S; Scambia G; Giordano A
    Clin Cancer Res; 2000 Dec; 6(12):4816-22. PubMed ID: 11156240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma.
    Davidson B; Reich R; Goldberg I; Gotlieb WH; Kopolovic J; Berner A; Ben-Baruch G; Bryne M; Nesland JM
    Clin Cancer Res; 2001 Mar; 7(3):551-7. PubMed ID: 11297247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the cyclin-dependent kinase inhibitor p21Cip1 in epithelial ovarian tumors of low malignant potential and adenocarcinomas.
    Vassilopoulos I; Korkolopoulou P; Konstantinidou AE; Patsouris E; Eftichiadis C; Thymara I; Perdiki M; Pavlakis K; Agapitos E; Davaris PS
    Histol Histopathol; 2003 Jul; 18(3):761-70. PubMed ID: 12792888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sam68 is Overexpressed in Epithelial Ovarian Cancer and Promotes Tumor Cell Proliferation.
    Dong L; Che H; Li M; Li X
    Med Sci Monit; 2016 Sep; 22():3248-56. PubMed ID: 27623016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.